newsfilter
← Latest News
GlobeNewswire·

CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced the addition of +PlusCBD Relief